Latest filing published 17 Jun 2020 for Evofem Biosciences, Inc., €13k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
William Walmsley Hall: trading record in brief
William Walmsley Hall discloses dealings in Evofem Biosciences, Inc. to SEC (Form 4). The record holds 2 filings, all for trades on 15 June 2020.
Every open-market trade on record is a purchase: 2 purchases worth €25k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The latest filing, published on 18 June 2020, reports an open-market purchase of €13k in Evofem Biosciences, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to William Walmsley Hall
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$2.85Common StockSEC:0001618835-20-000198:0Canonical exit: 13 Sept 2020 (T+90)
1 of 1 declaration